Sankala Group’s CVS Health CVS Stock Holding History

Sankala Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$24.9K	Hold	350	–	–	0.02%	297
2025 Q4	$28K	Buy	+350	New	+$27.6K	0.02%	284

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sankala Group's CVS Position: Q1 2026 in Review

Sankala Group held its CVS Health (CVS) position steady in Q1 2026 at 350 shares worth $24.9K. The position accounts for 0.02% of the portfolio, ranked #297.

Sankala Group first reported a position in CVS in Q4 2025 and has held it in 2 quarters since. The position peaked at $28K in Q4 2025. 1,874 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Sankala Group held 350 shares of CVS Health worth $24.9K as of Q1 2026.
Sankala Group left its CVS Health share count unchanged in Q1 2026.
CVS Health made up 0.02% of Sankala Group's portfolio in Q1 2026, its #297 holding.
Sankala Group first reported a position in CVS Health in Q4 2025 and has held it in 2 quarters since.
Sankala Group's CVS Health position peaked at $28K in Q4 2025.
1,874 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Sankala Group's 13F filing for Q1 2026, filed 31 Mar 2026.